Hormone Optimization Programs | Longevity Forward Science

Focus	Prescription model
What It Covers	Testosterone injections, gels, or pellets Estrogen and progesterone therapy for menopause symptoms Thyroid hormone, DHEA, or pregnenolone Growth hormone secretagogue peptides Quarterly hormone panels Ongoing prescription management
Typical Cost	$150 to $500 per month
Evidence Level	Established for diagnosed conditions; no evidence that raising normal, age-appropriate hormone levels extends healthspan
Regulatory Status	Prescription drugs; FDA labeling restricts testosterone to diagnosed conditions, compounded hormones are not FDA-approved products, and growth hormone for anti-aging is not a lawful use
Watchouts	Treatment targets above the normal range Treatment for age-related decline without a diagnosis Growth hormone offered for aging Cardiovascular, prostate, breast, and clotting risks not discussed before starting
Questions To Ask	What diagnosis supports this prescription and which lab confirms it? Was testosterone measured twice, in the morning, before deciding? What is monitored and what result would stop treatment? Is this an FDA-approved product or a compounded one?

Parallel Coverage

Related Resources

This profile connects back into the article, glossary, and FAQ layers so overlapping coverage stays discoverable instead of fragmented.

How longevity medicine differs from conventional healthcare, what it typically involves, and where the evidence stands.

What longevity clinics offer, how they differ from traditional primary care, and questions worth asking before enrolling in one.

Answers to the most common questions about longevity science, healthspan, biological aging, and evidence-based interventions.